2-((2-((4-(((2-((2-Acrylamidoethyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)methyl)phenyl)amino)-5-(trifluoromethyl)-pyrimidin-4-yl)amino)-N-methylbenzamide

ID: ALA4777260

PubChem CID: 162643259

Max Phase: Preclinical

Molecular Formula: C29H27F3N8O4

Molecular Weight: 608.58

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O

Standard InChI:  InChI=1S/C29H27F3N8O4/c1-3-21(41)34-12-13-35-22-23(25(43)24(22)42)36-14-16-8-10-17(11-9-16)38-28-37-15-19(29(30,31)32)26(40-28)39-20-7-5-4-6-18(20)27(44)33-2/h3-11,15,35-36H,1,12-14H2,2H3,(H,33,44)(H,34,41)(H2,37,38,39,40)

Standard InChI Key:  HTADFAXGWGDWNE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 44 47  0  0  0  0  0  0  0  0999 V2000
    7.6230   -8.8323    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.2049   -8.2545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4136   -8.0394    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.7552   -9.5487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1414   -8.5943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9076   -8.6756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9159   -8.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8960   -9.5005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5736   -7.5744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1288  -12.3707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5955   -6.1469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3433   -8.3682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0891   -7.4011    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6259   -8.7677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3932   -3.9820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6175   -4.7153    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1943   -8.7457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3674   -7.8005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6395   -3.2878    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1827   -9.5707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1577  -10.7211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5408   -9.3159    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0335   -9.9481    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4366  -11.1221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8672  -11.1457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6019   -9.9261    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2181   -3.9937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4229  -11.9441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9907   -3.2618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1750   -9.8971    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6293   -8.2762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4610   -9.9700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1700   -6.8528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8518  -11.9734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4884   -8.3202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1962   -5.4253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7668   -8.7238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3393   -8.7017    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3235   -9.5267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2197   -7.4385    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.7357  -10.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7491   -9.8849    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0214  -11.0990    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3205  -10.6788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
 18 13  2  0
 17  7  1  0
 10 34  1  0
  9 18  1  0
  9 33  1  0
 37 35  2  0
 15 29  2  0
 17 20  2  0
 31 38  1  0
 25 34  2  0
 21 30  1  0
 36 16  1  0
  7 14  1  0
 27 16  1  0
 20 32  1  0
 14 12  1  0
 18  5  1  0
 26  8  2  0
 39 26  1  0
 30  8  1  0
 12  9  2  0
 24 28  1  0
  4 32  2  0
 11 36  1  0
  5 22  2  0
 23  4  1  0
 35 17  1  0
 39 23  1  0
  4 37  1  0
 33 11  1  0
 12  5  1  0
 21 24  2  0
 25 21  1  0
 39 38  2  0
 27 15  1  0
 28 10  2  0
 27 19  2  0
  6 31  2  0
  8  6  1  0
  6  2  1  0
  2 40  1  0
 24 41  1  0
 41 42  2  0
 41 43  1  0
 43 44  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4777260

    ---

Associated Targets(Human)

PTK2B Tclin Protein tyrosine kinase 2 beta (2827 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTK2 Tclin Focal adhesion kinase 1 (4730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGF1R Tclin Insulin-like growth factor I receptor (8605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRA Tclin Platelet-derived growth factor receptor alpha (5682 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A 172 (535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 608.58Molecular Weight (Monoisotopic): 608.2107AlogP: 3.26#Rotatable Bonds: 13
Polar Surface Area: 166.24Molecular Species: NEUTRALHBA: 10HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.27CX Basic pKa: 4.41CX LogP: 4.34CX LogD: 4.34
Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.08Np Likeness Score: -1.14

References

1. Li B,Li Y,Tomkiewicz-Raulet C,Dao P,Lietha D,Yen-Pon E,Du Z,Coumoul X,Garbay C,Etheve-Quelquejeu M,Chen H.  (2020)  Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma.,  63  (21): [PMID:33119295] [10.1021/acs.jmedchem.0c01059]

Source